WHO defends data after concluding Gilead’s remdesivir flopped Covid-19 trial, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Gilead has questioned the findings that concluded remdesivir does not help patients who have been admitted to hospital, saying the “emerging (WHO) data appears inconsistent”. Gilead was given data from the United Nations health agency’s trial 10 days ago, to give it an opportunity to react., Gilead has questioned the findings that concluded remdesivir does not help patients who have been admitted to hospital, saying the “emerging (WHO) data appears inconsistent”. Gilead was given data from the United Nations health agency’s trial 10 days ago, to give it an opportunity to react., , Read More

Leave a Reply

Your email address will not be published.